In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
July 1st, 2006 | 30 | No |
(3beta,5alpha,22beta,25S)-spirosolan-3-ol; 5alpha-tomatidan-3beta-ol; Tomatidin; Tomatidine
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | 5.92 | -2.28 | -35.82 | 3 | 3 | 1 | 46 | 416.67 | 0 | ↓ |
Note Type | Comments | Provided By |
---|---|---|
PUBCHEM_PATENT_ID | EP0399438A2; EP0399438B1; EP0838155A1; EP0985408A2; EP0995424A2; EP0995425A2; US4246346; US5239819; US5455157; US5614408; US5959180; WO1991016824A1; WO1998034471A1; WO1998052573A1; WO1999043837A1; WO1999052534A1; WO2000041545A2; WO2000066716A2 | IBM Patent Data |
Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
EBP-1-E | 3-beta-hydroxysteroid-delta(8),delta(7)-isomerase (cluster #1 Of 1), Eukaryotic | Eukaryotes | 583 | 0.29 | Binding ≤ 10μM |
SGMR1-3-E | Sigma Opioid Receptor (cluster #3 Of 6), Eukaryotic | Eukaryotes | 81 | 0.33 | Binding ≤ 10μM |
ERG2-2-F | C-8 Sterol Isomerase (cluster #2 Of 2), Fungal | Fungi | 387 | 0.30 | Binding ≤ 10μM |
Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
EBP_HUMAN | Q15125 | 3-beta-hydroxysteroid-delta(8),delta(7)-isomerase, Human | 583 | 0.29 | Binding ≤ 1μM |
ERG2_YEAST | P32352 | C-8 Sterol Isomerase, Yeast | 387 | 0.30 | Binding ≤ 1μM |
SGMR1_HUMAN | Q99720 | Sigma Opioid Receptor, Human | 81 | 0.33 | Binding ≤ 1μM |
EBP_HUMAN | Q15125 | 3-beta-hydroxysteroid-delta(8),delta(7)-isomerase, Human | 583 | 0.29 | Binding ≤ 10μM |
ERG2_YEAST | P32352 | C-8 Sterol Isomerase, Yeast | 387 | 0.30 | Binding ≤ 10μM |
SGMR1_HUMAN | Q99720 | Sigma Opioid Receptor, Human | 81 | 0.33 | Binding ≤ 10μM |
Description | Species |
---|---|
Cholesterol biosynthesis |